Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion type Assertion NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_head.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion description "[The engineered CD4(+) T cells and CD8(+) T cells both exhibited specific cytotoxicity against CD19(+) leukemia and lymphoma cell lines, as well as against CD19 transfectants, and produced high-levels of antigen-dependent Th1 (but not Th2) cytokines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_provenance.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion evidence source_evidence_literature NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_provenance.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion SIO_000772 18227839 NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_provenance.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion wasDerivedFrom befree-2016 NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_provenance.
- NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_assertion wasGeneratedBy ECO_0000203 NP652291.RAUfpiVf0N56I7Rlwl3cD5AJLHVdxaAKyk3NyqsaIJ45s130_provenance.